Constitutive activation of the AMPK-Bmi1-GATA2 axis can mediate MICA/B inhibition, which may serve as a therapeutic target for further intervention of immune escape in pancreatic cancer (171). The gene discussed is BMI1; the disease is familial pancreatic carcinoma.